Log In
Print
BCIQ
Print
Print this Print this
 

Empatic (zonisamide SR/bupropion SR)

Also known as: formerly Excalia

  Manage Alerts
Collapse Summary General Information
Company Orexigen Therapeutics Inc.
DescriptionFixed dose combination of bupropion, a dopamine and norepinephrine reuptake inhibitor, and anticonvulsant zonisamide
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationObesity
Indication DetailsTreat obesity
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today